Affordable Access

Publisher Website

Impact of transcription factors AP-1 and NF-κB on the outcome of experimentalStaphylococcus aureusarthritis and sepsis

Elsevier SAS
Publication Date
DOI: 10.1016/s1286-4579(01)01408-3
  • Transcription Factors
  • Nf-κB
  • Ap-1
  • Staphylococcus Aureus
  • Arthritis
  • Biology
  • Medicine


Abstract Staphylococcus aureus infection is, despite adequate antibiotic treatment, a disease characterized by high mortality. The bacterium triggers an exaggerated immune response in the host, which on the one hand acts as an efficient defense, but on the other hand gives rise to tissue damage. In this study we have modulated the hostˈs response to S. aureus by inhibition of nuclear factor κB (NF-κB) and activator protein-1 (AP-1)-triggered release of pro-inflammatory cytokines and tissue-destructive proteins, respectively. Mice were administered with antisense oligonucleotides (ODN) to the p65 subunit of NF-κB and/or a double-stranded oligonucleotide (mCoAP-1) with homology to the murine AP-1 binding site of collagenase IV gene (metalloproteinase-9; MMP-9), solely or in combination with antibiotics. In mice systemically treated with antisense ODN to NF-κB p65 alone, the bacterial burden in the kidneys was significantly increased ( P = 0.04) The same tendency was seen when mCoAP-1 was administered either alone or in combination with antibiotics. We also found significantly ( P = 0.04) elevated levels of IL-6 in p65 antisense treated mice. Surprisingly, this p65 antisense therapy approach, which has turned out to be highly efficient in amelioration of aseptic arthritis and colitis, failed to change the clinical course of either septic arthritis or sepsis. We suggest that interaction with transcription factors leads to increased bacterial burden in vivo, abrogating the potential benefits of the anti-inflammatory properties exerted by these compounds.

There are no comments yet on this publication. Be the first to share your thoughts.